Hiring subsidies for people with a disability: do they work?


Journal

The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 19 02 2018
accepted: 04 01 2019
pubmed: 16 1 2019
medline: 14 1 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

This article evaluates the effectiveness of hiring subsidies targeted to people with disabilities. By exploiting the timing of implementation among different Spanish regions of a subsidy scheme implemented in Spain during the period 1990-2014, we employed a difference-in-differences approach to estimate the impact of the scheme on the probability of disability insurance (DI) beneficiaries of transiting to employment and on the propensity of individuals of entering the DI program. Our results show that the introduction of the subsidy scheme is in general ineffective at incentivizing transitions to employment, and in some cases it is associated with an increased propensity of transiting to DI. Furthermore, we show that an employment protection component incorporated into the subsidy scheme, consisting in the obligation for the employer to maintain the subsidized worker in employment, is associated with less transitions to permanent employment, more transitions to temporary employment and more transitions to DI, suggesting that these type of employment protection measures can have undesired effects for people with disabilities.

Identifiants

pubmed: 30644004
doi: 10.1007/s10198-019-01030-9
pii: 10.1007/s10198-019-01030-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

669-689

Subventions

Organisme : Recercaixa
ID : Promoting the labour market integration of disabled workers: A policy evaluation exercise for Spain
Organisme : Spanish Ministry of Economy
ID : ECO2014-52238-R

Références

J Econ Perspect. 2006 Summer;20(3):71-96
pubmed: 17176528
J Public Econ. 2011 Oct;95(9-10):1223-1235
pubmed: 21969737
Eur J Health Econ. 2016 Jan;17(1):71-86
pubmed: 25501259
J Econ Perspect. ;29(2):151-72
pubmed: 28443648
Am Econ Rev. 2014 Feb;104(2):624-55
pubmed: 29533562

Auteurs

Sergi Jiménez-Martín (S)

Universitat Pompeu Fabra, Barcelona GSE and FEDEA, Barcelona, Spain.

Arnau Juanmartí Mestres (A)

Centre for Research in Health and Economics, Universitat Pompeu Fabra (CRES-UPF), Barcelona, Spain.

Judit Vall Castelló (J)

Department of Economics and Institut d'Economia de Barcelona (IEB), Universitat de Barcelona and CRES-UPF, Barcelona, Spain. judit.vall@ub.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH